By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Horizon Pharma plc 

Connaught House, 1st Floor
1 Burlington Road
Dublin 4      Ireland
Phone: +353-1-72-2100 Fax:


Company News
Amidst Hostile Takeover Attempt of Depomed (DEPO), Horizon Pharma (HZNP) Triples Size of U.S. Headquarters 10/5/2015 6:14:31 AM
Horizon Pharma (HZNP) Announces Settlement Of RAYOS(R) (prednisone) Delayed-Release Tablets Patent Litigation With Actavis Laboratories FL Inc. 10/2/2015 10:50:20 AM
Horizon Pharma (HZNP) Announces Leading Proxy Advisory Service, Glass Lewis & Co., Recommends Depomed (DEPO) Shareholders Provide Consent FOR The Two Special Meeting Requests 9/30/2015 1:08:13 PM
Horizon Pharma (HZNP) Receives Positive CHMP Opinion For RAVICTI (Glycerol Phenylbutyrate) Oral Liquid For The Treatment Of Urea Cycle Disorders In Patients Greater Than Two Months Of Age 9/29/2015 12:04:11 PM
Horizon Pharma (HZNP) Has Commenced Solicitation Of Depomed (DEPO) Shareholders For Calling Of Special Meetings 9/14/2015 1:14:58 PM
Bay Area Depomed (DEPO) Rejects Horizon Pharma (HZNP)'s Latest Takeover Offer 9/14/2015 11:25:59 AM
Horizon Pharma (HZNP) To Present At The Morgan Stanley Global Healthcare Conference 9/9/2015 9:32:18 AM
Horizon Pharma (HZNP) Commences Exchange Offer To Acquire All Depomed (DEPO) Common Shares 9/8/2015 12:22:09 PM
Depomed (DEPO) Issues Statement On Horizon Pharma (HZNP)'s Unsolicited Exchange Offer 9/8/2015 9:11:28 AM
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID (Diclofenac Sodium Topical Solution) 2% 9/2/2015 11:36:21 AM